Cyclin-dependent kinase inhibitor for advanced breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cyclin-dependent Kinase Inhibitor for Advanced Breast Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305408/all/Cyclin_dependent_kinase_inhibitor_for_advanced_breast_cancer.
Cyclin-dependent kinase inhibitor for advanced breast cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305408/all/Cyclin_dependent_kinase_inhibitor_for_advanced_breast_cancer. Accessed November 7, 2024.
Cyclin-dependent kinase inhibitor for advanced breast cancer. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305408/all/Cyclin_dependent_kinase_inhibitor_for_advanced_breast_cancer
Cyclin-dependent Kinase Inhibitor for Advanced Breast Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305408/all/Cyclin_dependent_kinase_inhibitor_for_advanced_breast_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cyclin-dependent kinase inhibitor for advanced breast cancer
ID - 1305408
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305408/all/Cyclin_dependent_kinase_inhibitor_for_advanced_breast_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -